During the annual session of the WHO Regional Committee for Europe in September 2016, the member states adopted the European action plan for the health sector response to viral hepatitis. This is the first action plan for the region and aims at guiding countries to achieve the set goal of eliminating viral hepatitis as a public health threat by 2030.
In order to eliminate viral hepatitis as a public health threat by 2030, Europe needs to focus on testing, treatment and surveillance. Courtesy of European Centre for Disease Prevention and Control
During the annual session of the WHO Regional Committee for Europe in September 2016, the member states adopted the European action plan for the health sector response to viral hepatitis. This is the first action plan for the region and aims at guiding countries to achieve the set goal of eliminating viral hepatitis as a public health threat by 2030.
The action plan provides regional milestones and targets across the continuum of viral hepatitis services and proposes priority actions for member states.
Currently, the countries of the European Union and European Economic Area report around 57,000 newly diagnosed acute and chronic cases of hepatitis B and C each year. And these figures most likely represent an underestimate of the true situation. Instead, it is believed that an estimated 10 million Europeans have chronic hepatitis B and C infection, most of them without knowing it as hepatitis is largely asymptomatic.
Data indicate a greater disease burden for hepatitis C compared with hepatitis B across Europe: numbers and notification rates for hepatitis C infection are nearly twice as high as those reported for hepatitis B. Read about recent data and trends here.
A systematic review on Hepatitis A virus (HAV) seroprevalence and Hepatitis A incidence in EU/EEA countries shows that although HAV circulation has been decreasing steadily over the past four decades, an increasing proportion of the EU/EEA population has become susceptible to HAV infection.
This first European Action Plan provides an important driver to aid countries in their fight against viral hepatitis, to which ECDC had the opportunity to contribute directly. Currently, the available surveillance data show on-going transmission of hepatitis in Europe and in order to interrupt this chain and to prevent further infections, European countries need to strengthen local prevention and control practices as outlined in the plan.
To achieve elimination of viral hepatitis by 2030, European countries need to ensure that:
•those who might be unknowingly infected with viral hepatitis need to be identified through more effective testing and screening programs;
•treatment programs and coverage of local prevention and control practices (e.g., harm reduction, vaccination, prevention of mother-to-child transmission) are scaled up to interrupt existing transmission chains and to reduce morbidity and mortality;
•national surveillance systems need to be improved to better reflect the local burden of viral hepatitis.
It is especially important that those most at-risk for hepatitis have easier access to testing, for example, people who inject drugs, men who have sex with men or migrants from countries where the prevalence viral hepatitis is high. As reaching and testing those at risk of infection is still a public health challenge across Europe, ECDC also backs the efforts of the European HIV-Hepatitis testing week.
In order to help countries assess the hepatitis disease burden, evaluate existing prevention and control strategies and to define epidemiological trends or transmission patterns, ECDC coordinates efforts to improve the EU-wide surveillance data for hepatitis A, B and C.
Source: European Centre for Disease Prevention and Control (ECDC)
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
2 Commerce Drive
Cranbury, NJ 08512